Issue 1/2004
Content (12 Articles)
A novel assay for the quantification of invasion from raft cultures of lung carcinomas
Victor Okoh, Geoffrey D. Young, Thomas S. Winokur, Robert I. Garver Jr.
An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer
Matthew H. Katz, Shinako Takimoto, Daniel Spivack, A.R. Moossa, Robert M. Hoffman, Michael Bouvet
A systemic antitumor immune response prevents outgrowth of lung tumors after i.v. rechallenge but is not able to prevent growth of experimental liver tumors
Frederieke H. van Duijnhoven, Remco I.J.M. Aalbers, Joost Rothbarth, Onno T. Terpstra, Peter J.K. Kuppen
Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice
Julie A. Sharp, Mark Waltham, Elizabeth D. Williams, Michael A. Henderson, Erik W. Thompson
Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer
Gaynor Davies, Giles H. Cunnick, Robert E. Mansel, Malcolm D. Mason, Wen G. Jiang
TNF-α promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line
Yoshinari Mochizuki, Hayao Nakanishi, Yasuhiro Kodera, Seiji Ito, Yoshitaka Yamamura, Tomoyuki Kato, Kenji Hibi, Seiji Akiyama, Akimasa Nakao, Masae Tatematsu
5-Aza-2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis
Jeong-Seok Nam, Yoshinori Ino, Yae Kanai, Michiie Sakamoto, Setsuo Hirohashi
Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer
Yoichi Yamada, Naoki Itano, Hisashi Narimatsu, Takashi Kudo, Kyoei Morozumi, Setsuo Hirohashi, Atsushi Ochiai, Minoru Ueda, Koji Kimata
Measurement of tumor load and distribution in a model of cancer-induced osteolysis: A necessary precaution when testing novel anti-resorptive therapies
R. Nic Amhlaoibh, P. Hoegh-Andersen, N. Brünner, A. Sørensen, B. Winding, C. Holst-Hansen, M.A. Karsdal, M.T. Engsig, J.M. Delaissé, A.M. Heegaard
Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients
C. Wilmanns, J. Grossmann, S. Steinhauer, G. Manthey, B. Weinhold, A. Schmitt-Gräff, B.-U. von Specht
p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases
Anand G. Menon, Rob A.E.M. Tollenaar, Cornelis J.H. van de Velde, Hein Putter, Connie M. Janssen-van Rhijn, Rob Keijzer, Gert Jan Fleuren, Peter J.K. Kuppen